You are here

Home

Szekanecz Zoltán

Szekanecz Zoltán

Szekanecz Zoltán
DE > ÁOK
tanszékvezető egyetemi tanár 2001-
Name: Szekanecz Zoltán
Affiliation: Debreceni Egyetem. Általános Orvostudományi Kar. Belgyógyászati Intézet. Reumatológiai Tanszék / University of Debrecen. Faculty of Medicine. Department of Internal Medicine. Division of Rheumatology
Other profiles: Facebook, LinkedIn, MTMT, ResearchGate
Degree
  • az orvostudományok kandidátusa, MTA (1995)
  • az MTA doktora, MTA (2001)
Profession: rheumatologist, internist, immunologist

Publication list

printer-friendly version
Export to MTMT compatible RIS file
Upload publications
Request certified publication list
Uploaded publications:
754
Publications in DEA:
734
OA:
202
Date range:
1989-2025
2025
  1. Bender, T., Szekanecz, É., Gomez, I., Péntek, I., Maráz, A., Dank, M., Szekanecz, Z.: Daganatos betegek fizioterápiája - narratív összefoglaló és szakértői vélemény.
    Magyar Onkol. 69 (1), 241-249, 2025.
    Journal metrics:
    Q4 Medicine (miscellaneous) (2023)
    Q4 Oncology (2023)
2024
  1. Haugen, I., Felson, D., Abhishek, A., Berenbaum, F., Bierma-Zeinstra, S., Dziedzic, K., Edwards, J., Englund, M., Hermann-Eriksen, M., Herrero-Beaumont, G., Hill, C., Ishimori, M., Jonsson, H., Karjalainen, T., Leung, Y., Maheu, E., Mallen, C., Marshall, M., Moe, R., Ramonda, R., Ritschl, V., Ritt, M., Stamm, T., Szekanecz, Z., Giesen, F., Stadt, L., Meulen, C., Wittoek, R., Greibrokk, E., Laheij, H., Kloppenburg, M.: 2023 EULAR classification criteria for hand osteoarthritis.
    Ann. Rheum. Dis. [Epub ahead of print]2024.
    Journal metrics:
    D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    D1 Immunology (2023)
    D1 Immunology and Allergy (2023)
    D1 Rheumatology (2023)
  10. Szekanecz, Z., Besnyi, A., Kónya, P., Füri, J., Király, E., Bertalan, É., Falus, G., Udvardi, B., Kovács-Kiss, V., Andrássy, L., Maros, G., Fancsik, T., Pethő, Z., Gomez, I., Horváth, Á., Gulyás, K., Juhász, B., Hódosi, K., Jakabné Sándor, Z., Bhattoa, H., Kovács, I.: Bones or Stones: how Can We Apply Geophysical Techniques in Bone Research?.
    Int. J. Mol. Sci. 25 (19), 1-16, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  11. Szűcs, G., Szekanecz, Z., Szamosi, S.: Can we define difficult-to-treat systemic sclerosis?.
    Expert Rev. Clin. Immunol. [Epub ahead of print]2024.
    Journal metrics:
    Q2 Immunology (2023)
    Q2 Immunology and Allergy (2023)
  12. Zimmerman, D., Szekanecz, Z., Markovics, A., Rosenthal, K., Carambula, R., Mikecz, K.: Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines.
    Front. Immunol. 15 1-13, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    Q1 Immunology and Allergy (2023)
  13. Taylor, P., Choy, E., Baraliakos, X., Szekanecz, Z., Xavier, R., Isaacs, J., Strengholt, S., Parmentier, J., Lippe, R., Tanaka, Y.: Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases.
    RHEUMATOLOGY. 63 (2), 298-308, 2024.
    Journal metrics:
    D1 Pharmacology (medical) (2023)
    D1 Rheumatology (2023)
  14. Tóth, E., Fagyas, M., Nagy, B., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
    GeroScience. 46 (2), 1561-1574, 2024.
    Journal metrics:
    Q1 Aging (2023)
    Q1 Cardiology and Cardiovascular Medicine (2023)
    D1 Complementary and Alternative Medicine (2023)
    Q1 Geriatrics and Gerontology (2023)
    D1 Veterinary (miscellaneous) (2023)
  15. Szekanecz, Z., Buch, M., Charles-Schoeman, C., Galloway, J., Karpouzas, G., Kristensen, L., Ytterberg, S., Hamar, A., Fleischmann, R.: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
    Nat. Rev. Rheumatol. 20 (2), 101-115, 2024.
    Journal metrics:
    D1 Rheumatology (2023)
  16. Sebbag, E., Lauper, K., Molina-Collada, J., Aletaha, D., Askling, J., Gente, K., Bertheussen, H., Bitoun, S., Bolek, E., Burmester, G., Canhão, H., Chatzidionysiou, K., Curtis, J., Danlos, F., Guimarães, V., Hetland, M., Iannone, F., Kostine, M., Kragstrup, T., Kvien, T., Regierer, A., Schulze-Koops, H., Silva-Fernández, L., Szekanecz, Z., Buch, M., Finckh, A., Gottenberg, J.: EULAR Points to Consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
    Ann. Rheum. Dis. "Accepted by Publisher"2024.
    Journal metrics:
    D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    D1 Immunology (2023)
    D1 Immunology and Allergy (2023)
    D1 Rheumatology (2023)
  20. Szekanecz, Z., Osadcii-Zaiat, D., Bajkó, A., Minda, H., Szerencsés, D.: Key personal insights and changing needs of osteoarthritis patients: an international quantitative survey analysis.
    Reumatologia. 62 (6), 1-7, 2024.
    Journal metrics:
    Q4 Immunology (2023)
    Q3 Immunology and Allergy (2023)
    Q3 Rheumatology (2023)
  21. Szekanecz, V., Lekli, L., Kardos, Z., Kardos, V., Szekanecz, Z.: Kognitív diszfunkció autoimmun reumatológiai kórképekben.
    Magyar Reum. 65 188-193, 2024.
  22. Szekanecz, Z., Szamosi, S., Benkő, S., Szűcs, G.: Monogénesen öröklődő és szerzett autoinflammatoricus betegségek.
    Orv. hetil. 165 (18), 683-697, 2024.
    Journal metrics:
    Q4 Medicine (miscellaneous) (2023)
  23. Simon, D., Kacsándi, D., Karancsiné Pusztai, A., Soós, B., Végh, E., Kerekes, G., Czókolyová, M., Szamosi, S., Szűcs, G., Prohászka, Z., Németh, P., Berki, T., Szekanecz, Z.: Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: associations with Vascular Pathophysiology.
    Int. J. Mol. Sci. 25 (6), 1-14, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  24. Szekanecz, Z., Buch, M., Charles-Schoeman, C., Galloway, J., Karpouzas, G., Kristensen, L., Ytterberg, S., Hamar, A., Fleischmann, R.: Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis : update for the practising clinician (Nature Reviews Rheumatology, (2024), 20, 2, (101-115), 10.1038/s41584-023-01062-9).
    Nat. Rev. Rheumatol. 20 (3), 196, 2024.